title: Trastuzumab for gastric cancer treatment.
authors.forename: Alicia Fc
authors.initials: AF
authors.lastname: Okines
authors.forename: Alice
authors.initials: A
authors.lastname: Dewdney
authors.forename: Ian
authors.initials: I
authors.lastname: Chau
authors.forename: Sheela
authors.initials: S
authors.lastname: Rao
authors.forename: David
authors.initials: D
authors.lastname: Cunningham
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality; D005260:Female; D006801:Humans; D010166:Palliative Care; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D015996:Survival Rate; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab